Resilience study for people with opioid use disorder
Part of Mental health clinical trials.
This study looks at resilience in people with opioid use disorder. Researchers want to understand what helps people stay strong and recover. You may be able to join if you are currently using opioids or receiving treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have been diagnosed with opioid use disorder or are currently on treatment like methadone or buprenorphine.
- You test positive for opioids in a urine sample.
- You can understand and agree to the study procedures.
- You are not pregnant or breastfeeding.
- You do not have a major mental or physical health issue that would make it hard to take part.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a program to help new mothers recovering from opioid use disorder by involving a support person. It aims to improve recovery and well-being during the first weeks after childbirth.
This study aims to better understand how people experience opioid withdrawal. You will be asked to describe your symptoms, which may help develop a new tool to measure withdrawal more accurately.
This trial tests whether psilocybin can help people recovering from opioid use disorder while living at a residential treatment center. If you are already taking buprenorphine/naloxone (Suboxone), methadone, or have received Sublocade, this study may be an option for you.
This trial studies a program meant to improve treatment access and support recovery for people with opioid use disorder who also have mental health symptoms. It may help if you are new to the program or recently relapsed, or if mental health symptoms have worsened—even without a relapse.
This study looks at how people recovering from opioid use disorder get along with a close friend or family member (called a CSO). It may help improve social support during early treatment.
This study looks at how stress and the body’s natural opioid/cannabinoid systems may relate to risk of opioid misuse. It tests people with long-lasting low back pain to see what biological or psychological factors might increase or lower that risk.
Hear when a new Opioid Use Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.